scholarly journals Clonal lineages and antimicrobial resistance of nonencapsulated Streptococcus pneumoniae in the post-pneumococcal conjugate vaccine era in Japan

2021 ◽  
Vol 105 ◽  
pp. 695-701
Author(s):  
Mitsuyo Kawaguchiya ◽  
Noriko Urushibara ◽  
Meiji Soe Aung ◽  
Kenji Kudo ◽  
Masahiko Ito ◽  
...  
2016 ◽  
Vol 60 (11) ◽  
pp. 6664-6672 ◽  
Author(s):  
Tatiana C. A. Pinto ◽  
Fabíola C. O. Kegele ◽  
Cícero A. G. Dias ◽  
Rosana R. Barros ◽  
José M. Peralta ◽  
...  

ABSTRACTAntimicrobial-resistant pneumococcal strains have been detected worldwide since the 1960s. In Brazil, the first penicillin-nonsusceptible pneumococci (PNSP) were reported in the 1980s, and their emergence and dissemination have been mainly attributed to serogroup 9 and serotype 14 strains, especially those highly related to recognized international clones. In the present study, antimicrobial susceptibility testing and multilocus sequence typing were performed on 315 pneumococcal isolates belonging to serogroup 9 (n= 99) or serotype 14 (n= 216), recovered from patients or asymptomatic carriers between 1988 and 2011 in Brazil, in order to trace changes in antimicrobial resistance and genotypes prior to the full introduction of the pneumococcal conjugate vaccine in the country. Over the 23-year study period, the PNSP levels increased, and four clonal complexes (CC156, CC66, CC15, and CC5401) have played important roles in the evolution and dissemination of pneumococcal isolates belonging to serogroup 9 and serotype 14, as well as in the emergence of antimicrobial resistance, in the pre-pneumococcal-vaccination era. The earliest PNSP strains detected in this study belonged to serotype 9N/ST66 and were single locus variants of the international clone Tennessee14-18 ST67 (CC66). The first serotype 14 PNSP isolates were identified in 1990 and were related to the England14-9 ST9 (CC15) clone. Serotype 14 PNSP variants of the Spain9V-3 ST156 clone with elevated penicillin MICs and nonsusceptibility to other beta-lactams were detected in 1995 and showed an increasing trend over the years. The results also indicated that introduction of ST156 in our region was preceded by the emergence of trimethoprim-sulfamethoxazole resistance and by the dissemination of ST162. In addition to the presence of successful international clones, a novel regional serotype 14 genotype (CC5401) has emerged in 1996.


F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 221
Author(s):  
Xu Han ◽  
Niurka Molina Águila ◽  
Haiyang Yu ◽  
C. Nivaldo Linares Pérez ◽  
C. María Eugenia Toledo Romaní

The World Health Organization (WHO) recommends that pneumococcal conjugate vaccines (PCVs) be included in immunization programs worldwide. In China, the 7-valent pneumococcal conjugate vaccine (PREVNAR 7®) was authorized in 2008 but was not included in the national immunization programs. In 2016, PREVNAR 13®, a 13-valent pneumococcal conjugate vaccine (PCV13), was licensed for optional use in China. We will conduct a scoping review of the distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae in children aged under 5 years in China since the introduction of PCV13. We will obtain data from PubMed, the China National Knowledge Infrastructure (CNKI), and Wanfang Med Online. We will also review epidemiological data from WHO and the China Antimicrobial Surveillance Network (CHINET). Our analysis will include the condition of interest, the intervention, and the geographical region. All types of studies will be eligible for inclusion in the study database if they meet the inclusion criteria. This scoping review is intended to outline how S. pneumoniae serotypes are distributed, and it will map their antimicrobial resistance in children aged under 5 years in China. The results of this study will provide useful information on the impact of PCV13 in China.


Vaccine ◽  
2011 ◽  
Vol 29 (6) ◽  
pp. 1139-1144 ◽  
Author(s):  
Ana Paula de O. Menezes ◽  
Leila C. Campos ◽  
Milena S. dos Santos ◽  
Jailton Azevedo ◽  
Renan C.N. dos Santos ◽  
...  

Vaccine ◽  
2016 ◽  
Vol 34 (4) ◽  
pp. 531-539 ◽  
Author(s):  
Astrid A.T.M. Bosch ◽  
Marlies A. van Houten ◽  
Jacob P. Bruin ◽  
Alienke J. Wijmenga-Monsuur ◽  
Krzysztof Trzciński ◽  
...  

Vaccine ◽  
2015 ◽  
Vol 33 (5) ◽  
pp. 628-634 ◽  
Author(s):  
Marta C. Nunes ◽  
Stephanie A. Jones ◽  
Michelle J. Groome ◽  
Locadiah Kuwanda ◽  
Nadia Van Niekerk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document